Most people with abdominal cancers are diagnosed with an advanced form of the disease.
The Hospital Research Foundation Group is proud to support research and equipment which improves the outcomes of patients with stomach and abdominal cancers.
Stomach Cancer Support
The purchase of a revolutionary new chemotherapy delivery system called PIPAC (Pressurised Intraperitoneal Aerosol Chemotherapy) for hard-to-treat abdominal cancers at The Queen Elizabeth Hospital.
The equipment is being used to treat cancers including bowel, ovarian, liver, oesophagus, pancreas and more.
Investigating whether a breath test can provide a cheap and non-invasive method of detecting oesophageal and gastric cancers and pre-cancerous lesions using odorant biomarkers.
Dr Ravi Vissapragada is driving the project which, if successful, would ultimately reduce the number of endoscopies needed.
Investigating a group of immune cells that could be a key target to predict whether a patient’s bowel cancer is likely to spread to the liver, known as liver metastasis.
Dr Kevin Fenix is building a biobank of liver metastatic bowel cancer tissue to analyse and identify biomarkers which will help predict whether bowel cancer is likely to spread
